IDH3A and glioma: Furthermore, although extensive research has established the significant role played by the isocitrate dehydrogenase (IDH) mutation and the 1p/19q codeletion in the diagnosis, treatment, and prognostic assessment of glioma, the prognosis for afflicted patients remains unfavorable [1].